NDC properties for "bismuth biskalcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline 125 MG Oral Capsule" (RxCUI 687231)
About this data
The tables show NDC propoerties for bismuth biskalcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline 125 MG Oral Capsule with the RxCUI 687231
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for bismuth biskalcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline 125 MG Oral Capsule (RxCUI 687231)
| RxCUI | 687231 |
|---|---|
| SNOMEDCT | 1222703002 |
| Prescribable Synonym | bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline 125 MG Oral Capsule |
| RXNAV_STR | bismuth biskalcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline 125 MG Oral Capsule |
| RxNorm Name | bismuth biskalcitrate 140 MG / metronidazole 125 MG / tetracycline 125 MG Oral Capsule |
| Tallman Synonym | bismuth biskalcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline 125 MG Oral Capsule |
| Related queries | Interactions (for RxCUI 687231) |
NDC Properties
no results for this query in NIH